ArticleLiver cancer2022

Period-Dependent Survival Benefit of Percutaneous Microwave Ablation for Hepatocellular Carcinoma: A 12-Year Real-World, Multicentric Experience.

Jie Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.